// App-Quantinova.ai

: Optimisation of potent topical SRPK1 inhibitors with improved retinal pharmacokinetics through ex vivo trans‐scleral permeability modelling

Researchers

Presenter

  • S. Liddell

Principal Investigators

  • H. Toop

  • E. Stewart

  • J. Daubney

  • J. Bourne

  • J. Batson

  • J. Morris

  • D. Bates

Medical Centers

  • Exonate Ltd, Cambridge, United Kingdom

  • School of Chemistry, University of New South Wales, Sydney, Australia

Locations

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved